Showing results (1831-1840 of 5,920) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|July 14, 2022
Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patientsYoann Roubertou, Sabine Mainbourg, Arnaud Hot, et al.
Arthritis Research & Therapy|June 20, 2019
Expression analysis of the osteoarthritis genetic susceptibility mapping to the matrix Gla protein gene MGPColin Shepherd, Abigail E Reese, Louise N Reynard, et al.
Arthritis Research & Therapy|June 15, 2019
Calorie restriction with regular chow, but not a high-fat diet, delays onset of spontaneous osteoarthritis in the Hartley guinea pig modelLauren B Radakovich, Angela J Marolf, Lauren A Culver, et al.
Arthritis Research & Therapy|June 15, 2019
Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammationCollin A Haraden, Janet L Huebner, Ming-Feng Hsueh, et al.
Arthritis Research & Therapy|July 7, 2019
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritisYoshiya Tanaka, Josef S Smolen, Heather Jones, et al.
Arthritis Research & Therapy|July 10, 2019
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic eraGabriella Giancane, Valentina Muratore, Valentina Marzetti, et al.
Arthritis Research & Therapy|July 10, 2019
Chondrogenic induction of human osteoarthritic cartilage-derived mesenchymal stem cells activates mineralization and hypertrophic and osteogenic gene expression through a mechanomiRNan Hu, Yun Gao, Chathuraka T Jayasuriya, et al.
Arthritis Research & Therapy|July 1, 2019
Comparison of an interactive voice response system and smartphone application in the identification of gout flaresNada Elmagboul, Brian W Coburn, Jeffrey Foster, et al.
Arthritis Research & Therapy|June 2, 2019
Gout, flares, and allopurinol use: a population-based studyCharlotte Proudman, Susan E Lester, David A Gonzalez-Chica, et al.
Arthritis Research & Therapy|June 8, 2019
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registryDenis Choquette, Louis Bessette, Evo Alemao, et al.
Pageof 592